Fidelity Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,933
| Closed | -$2.14M | – | 5378 |
|
|
2021
Q2 | $2.14M | Sell |
12,933
-427,273
| -97% | -$71.3M | ﹤0.01% | 2538 |
|
|
2021
Q1 | $67.5M | Buy |
440,206
+45,353
| +11% | +$6.16M | 0.01% | 1251 |
|
|
2020
Q4 | $49.5M | Buy |
394,853
+33,890
| +9% | +$3.79M | ﹤0.01% | 1329 |
|
|
2020
Q3 | $36.6M | Buy |
360,963
+360,608
| +101,580% | +$36.8M | ﹤0.01% | 1317 |
|
|
2020
Q2 | $35K | Sell |
355
-107,969
| -100% | -$10M | ﹤0.01% | 2873 |
|
|
2020
Q1 | $8.99M | Sell |
108,324
-161,308
| -60% | -$15.7M | ﹤0.01% | 1721 |
|
|
2019
Q4 | $30M | Buy |
269,632
+155,591
| +136% | +$16M | ﹤0.01% | 1432 |
|
|
2019
Q3 | $11.3M | Sell |
114,041
-720,121
| -86% | -$71.5M | ﹤0.01% | 1783 |
|
|
2019
Q2 | $82.7M | Sell |
834,162
-2,047,578
| -71% | -$195M | 0.01% | 994 |
|
|
2019
Q1 | $318M | Buy |
2,881,740
+292,887
| +11% | +$30.6M | 0.04% | 460 |
|
|
2018
Q4 | $238M | Buy |
2,588,853
+271,360
| +12% | +$27.5M | 0.03% | 523 |
|
|
2018
Q3 | $255M | Buy |
2,317,493
+21,818
| +1% | +$2.27M | 0.03% | 580 |
|
|
2018
Q2 | $214M | Buy |
2,295,675
+1,051,810
| +85% | +$90.6M | 0.02% | 632 |
|
|
2018
Q1 | $103M | Sell |
1,243,865
-134,540
| -10% | -$12M | 0.01% | 977 |
|
|
2017
Q4 | $126M | Sell |
1,378,405
-228,351
| -14% | -$19M | 0.01% | 891 |
|
|
2017
Q3 | $122M | Buy |
1,606,756
+1,006,684
| +168% | +$76.1M | 0.01% | 883 |
|
|
2017
Q2 | $45M | Sell |
600,072
-269,090
| -31% | -$18.7M | 0.01% | 1325 |
|
|
2017
Q1 | $56.7M | Sell |
869,162
-131,738
| -13% | -$7.76M | 0.01% | 1245 |
|
|
2016
Q4 | $55.2M | Sell |
1,000,900
-631,587
| -39% | -$34.7M | 0.01% | 1253 |
|
|
2016
Q3 | $92.3M | Sell |
1,632,487
-200,213
| -11% | -$9.82M | 0.01% | 1016 |
|
|
2016
Q2 | $76.5M | Sell |
1,832,700
-102,200
| -5% | -$4.71M | 0.01% | 1093 |
|
|
2016
Q1 | $82.7M | Sell |
1,934,900
-461,800
| -19% | -$19.5M | 0.01% | 1050 |
|
|
2015
Q4 | $108M | Sell |
2,396,700
-417,453
| -15% | -$17.5M | 0.01% | 939 |
|
|
2015
Q3 | $109M | Sell |
2,814,153
-114,404
| -4% | -$4.58M | 0.02% | 919 |
|
|
2015
Q2 | $106M | Sell |
2,928,557
-15,800
| -0.5% | -$500K | 0.01% | 1013 |
|
|
2015
Q1 | $84.9M | Sell |
2,944,357
-648,743
| -18% | -$18.1M | 0.01% | 1098 |
|
|
2014
Q4 | $87M | Buy |
+3,593,100
| New | +$81M | 0.01% | 1072 |
|
Other funds holding PRAH
Fidelity Investments's PRAH Position: Q3 2021 in Review
Fidelity Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 12,933 shares — an estimated $2.14M sold.
Fidelity Investments first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $318M in Q1 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Fidelity Investments reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Fidelity Investments sold 12,933 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.14M.
- Fidelity Investments first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Fidelity Investments's PRA Health Sciences, Inc. position peaked at $318M in Q1 2019.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Fidelity Investments's 13F filing for Q3 2021, filed 15 Nov 2021.